What To Pay Attention To & Why Biotech Is The Industry To Watch Right Now
- Over the last 3 months, the Health Care Select Sector SPDR Fund (XLV) has been climbing back toward its 52 week high.
- Both the SPDR S&P Biotech ETF (XBI) and the iShares NASDAQ Biotechnology Index ETF (IBB) have maintain their 2018 uptrend.
- Small cap biotech has been getting much more market play in comparison many of the large cap cohorts.
Earnings season continues to roll on this week as a number of companies report second quarter results. One of the standout sectors has been biotechnology and health-related stocks. In fact over the last 3 months, the Health Care Select Sector SPDR Fund (XLV) has been climbing back toward its 52 week high.
Likewise, both the SPDR S&P Biotech ETF (XBI) and the iShares NASDAQ Biotechnology Index ETF (IBB) have maintain their 2018 uptrend despite periodic consolidation throughout the year. With this in mind, investors have focused attention on the biotech and health sectors for new opportunities where some small cap issuers have begun to find a more active market during recent weeks.
Biotech Breakroom 